Williams Paul Anthony has filed 18 insider transactions across 1 company since February 2024.
Most recent transaction: a grant/award of 100111 shares of Emergent BioSolutions Inc. ($EBS) on April 29, 2026.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 29, 2026 | Emergent BioSolutions Inc. | $EBS | Williams Paul Anthony | SVP, Products Business | A | Common Stock | 100111 | $0.00 | 162,792.0000 | 56,700,000 | 159.72% | 0.18% |
| April 1, 2026 | Emergent BioSolutions Inc. | $EBS | Williams Paul Anthony | SVP, Products Business | S | Common Stock | 4000 | $8.44 | 62,681.0000 | 56,700,000 | 6.00% | 0.01% |
| March 3, 2026 | Emergent BioSolutions Inc. | $EBS | Williams Paul Anthony | SVP, Products Business | A | Employee Stock Option (Right to buy) | 44834 | $0.00 | 254,948.0000 | 56,700,000 | 21.34% | 0.08% |
| March 5, 2026 | Emergent BioSolutions Inc. | $EBS | Williams Paul Anthony | SVP, Products Business | F | Common Stock | 9397 | $8.44 | 66,681.0000 | 56,700,000 | 12.35% | 0.02% |
| March 1, 2026 | Emergent BioSolutions Inc. | $EBS | Williams Paul Anthony | SVP, Products Business | F | Common Stock | 116 | $8.15 | 76,078.0000 | 56,700,000 | 0.15% | 0.00% |
| Feb. 6, 2026 | Emergent BioSolutions Inc. | $EBS | Williams Paul Anthony | SVP, Products Business | F | Common Stock | 1022 | $10.92 | 76,194.0000 | 56,700,000 | 1.32% | 0.00% |
| Feb. 6, 2026 | Emergent BioSolutions Inc. | $EBS | Williams Paul Anthony | SVP, Products Business | D | Common Stock | 8655 | $10.92 | 77,216.0000 | 56,700,000 | 10.08% | 0.02% |
| June 8, 2025 | Emergent BioSolutions Inc. | $EBS | Williams Paul Anthony | SVP, Products Business | F | Common Stock | 464 | $6.63 | 85,871.0000 | 53,000,000 | 0.54% | 0.00% |
| March 6, 2025 | Emergent BioSolutions Inc. | $EBS | Williams Paul Anthony | SVP, Products Business | A | Common Stock | 62500 | $0.00 | 86,335.0000 | 53,000,000 | 262.22% | 0.12% |
| March 6, 2025 | Emergent BioSolutions Inc. | $EBS | Williams Paul Anthony | SVP, Products Business | A | Employee Stock Options (Right to Buy) | 62500 | $0.00 | 210,114.0000 | 53,000,000 | 42.34% | 0.12% |
| March 1, 2025 | Emergent BioSolutions Inc. | $EBS | Williams Paul Anthony | SVP, Products Business | F | Common Stock | 116 | $7.48 | 23,835.0000 | 53,000,000 | 0.48% | 0.00% |
| Feb. 28, 2025 | Emergent BioSolutions Inc. | $EBS | Williams Paul Anthony | SVP, Products Business | F | Common Stock | 382 | $7.48 | 23,951.0000 | 53,000,000 | 1.57% | 0.00% |
| July 8, 2024 | Emergent BioSolutions Inc. | $EBS | Williams Paul Anthony | SVP, Products Business | F | Common Stock | 85 | $8.13 | 24,333.0000 | 51,200,000 | 0.35% | 0.00% |
| June 8, 2024 | Emergent BioSolutions Inc. | $EBS | Williams Paul Anthony | SVP, Products Business | F | Common Stock | 464 | $6.19 | 24,418.0000 | 51,200,000 | 1.86% | 0.00% |
| March 13, 2024 | Emergent BioSolutions Inc. | $EBS | Williams Paul Anthony | SVP, Products Business | A | Employee Stock Options (Right to Buy) | 125000 | $0.00 | 147,614.0000 | 51,200,000 | 552.75% | 0.24% |
| Feb. 29, 2024 | Emergent BioSolutions Inc. | $EBS | Williams Paul Anthony | SVP, Products Business | F | Common Stock | 450 | $3.23 | 25,019.0000 | 51,200,000 | 1.77% | 0.00% |
| March 1, 2024 | Emergent BioSolutions Inc. | $EBS | Williams Paul Anthony | SVP, Products Business | F | Common Stock | 137 | $3.39 | 24,882.0000 | 51,200,000 | 0.55% | 0.00% |
| Feb. 23, 2024 | Emergent BioSolutions Inc. | $EBS | Williams Paul Anthony | SVP, Products Business | F | Common Stock | 105 | $2.74 | 25,469.0000 | 51,200,000 | 0.41% | 0.00% |